To the Editor:

SEVERE elevation of D-dimer is a hallmark of septic shock and a predictor of mortality in coronavirus-2019 (COVID-19) disease.[@bib0001] D-dimer reflects the extent of plasmin-mediated degradation of cross-linked fibrin, thereby causing intravascular coagulation. Use of thromboelastometry has gained popularity to assess systemic fibrinolysis in liver transplantation and major trauma,[@bib0002] but its utility has not been fully elaborated in the critical care setting.[@bib0003] We therefore analyzed the laboratory and thromboelastometry data from 11 critically ill patients receiving mechanical lung ventilation and intensive care support for COVID-19 at the R Adams Cowley Shock Trauma Center over a 2-day period. The Institutional Review Board approved the study. Patients were characterized as follows (data in median \[25%-75% quartiles\] or percentage); median age 53 years (45.5-65.5 y), body mass index 28.1 (27.1-34.6), 64% male, 54.5% hypertensive, and 45.5% diabetic. Patients were dichotomized into 2 groups on the basis of D-dimer levels 5 times the upper limit of normal (649 ng/mL fibrinogen equivalent unit). Three of 6 patients in the high D-dimer group were on extracorporeal membrane oxygenation support. Despite highly significant C-reactive protein and D-dimer elevations in the latter group, systemic fibrinolysis was not detected either on EXTEM or FIBTEM (maximal lysis 0%). D-dimer has a half-life of about 8 hours and reflects in vivo thrombus formation.[@bib0004] On the other hand, thromboelastometry only measures the reserve hemostasis capacity in the collected blood using a high-dose coagulation trigger (eg, tissue factor). Tissue plasminogen activator is an important trigger of fibrinolysis in vivo, but its half-life is normally less than 3 minutes.[@bib0005] Circulating plasminogen activator inhibitor-1 levels are increased during Severe Acute Respiratory Syndrome (SARS) corona virus infection.[@bib0006] Systemic fibrinolysis thus is unlikely to occur in COVID-19 patients with cytokine storm ([Table 1](#tbl0001){ref-type="table"} ).Table 1Laboratory Data of Patients with Moderate versus Severe D-Dimer ElevationsTable 1D-Dimer (ng/mL)≤3,245\>3,245Standard laboratoryn = 5n = 6 CRP (mg/dL)4.9 (3.8-26.1)27.5 (13.0-32.7) D-dimer (ng/mL)2,410 (1,220-2,800)15,465 (8,050-19,730) Fibrinogen (mg/dL)478 (351-1,057)734 (567-1,016) Hematocrit (%)28.4 (24.4-30.3)25.9 (22.1-28.7) Platelet (× 10^9^/mL)211 (152-269)144 (104-301) PT (sec)14.7 (13-14.7)15.1 (14.9-15.4)Thromboelastometry EXTEM-CT (s)73 (69-74)76.5 (73-91.5) EXTEM-A10 (mm)63 (60-70)67 (61.5-68.9) FIBTEM-A10 (mm)30 (30-36)36.5 (32.8-43.4) EXTEM-ML (%)00[^1][^2]

Raza et al. previously showed that only 5% of trauma patients had fibrinolysis on ROTEM, whereas 57% of patients had moderate fibrinolysis with a median D-dimer level of 38,687 ng/mL.[@bib0007] In our patients, a median D-dimer fibrinogen equivalent unit of 15,465 ng/mL and fibrinogen 734 mg/dL showed that only 0.21 % of fibrinogen was converted to D-dimer. In contrast, the data in the study by Raza et al showed that 1.84% of fibrinogen (median 210 mg/dL) was converted to D-dimer. Taken together, critically ill COVID-19 patients demonstrated significant elevations in D-dimer consistent with microvascular thromboses, but only small fractions of fibrin seem to be broken down locally and systemic fibrinolysis is rarely observed.
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[^1]: NOTE. Thromboelastometry was performed on the ROTEM Delta (TEM Innovations, Munich, Germany). EXTEM and FIBTEM reagents contain hexadimethrine bromide, that neutralizes heparin. Five patients in the high D-dimer group were on intravenous heparin. Reference ranges: C-reactive protein \<1 mg/dL; D-dimer \<640 ng/mL fibrinogen equivalent unit; fibrinogen 216-438 mg/dL; hematocrit 37%-50%; platelet 153-367 × 10^9^/mL; prothrombin time 9.6-11.2 sec; EXTEM clotting time 43-82 seconds; EXTEM clot amplitude at 10 minutes 46-67 mm; FIBTEM clot amplitude at 10 minutes 7-24 mm; EXTEM maximal lysis \<15%.

[^2]: Abbreviations: A10, clot amplitude at 10 minutes; CRP, C-reactive protein; CT, clotting time; ML, maximal lysis; PT, prothrombin time.
